Study Finds Early Deep Sedation May Raise One-Year Mortality After Critical Surgical Illness

Sedation in Focus: Why It Matters Beyond the ICU

Sedation is a cornerstone of intensive care, especially for patients requiring mechanical ventilation. While deep sedation can control agitation and ease patient management, emerging research reveals that its impact may extend far beyond the ICU walls. A new study published in BMC Anesthesiology, suggests that early deep sedation within the first three days of ICU admission is linked to higher one-year mortality in critically ill surgical patients after hospital discharge.

The Study: Tracking Sedation and Survival

Researchers retrospectively analyzed data from over 7,000 critically ill surgical patients admitted to surgical ICUs between 2015 and 2020. The depth of sedation was assessed using the Richmond Agitation-Sedation Scale (RASS), with deep sedation defined as an average RASS of –3 or lower during the first three ICU days. Survival data was meticulously gathered through the national death registry, ensuring robust long-term follow-up.

Key Findings: Deep Sedation Carries Long-Term Risks

13.7% of patients experienced early deep sedation.

One-year post-hospital mortality was significantly higher in patients with early deep sedation, even after adjusting for age, sex, comorbidities, severity of illness, and type of surgery.

Independent risk factors for mortality included older age, male sex, lower body mass index (BMI), higher comorbidity and severity scores, and undergoing neurosurgery or major abdominal surgery.

Patients sedated with midazolam or propofol had higher mortality than those receiving dexmedetomidine.

Propensity score matching confirmed the robustness of these results, minimizing confounding variables.

Implications: Sedation Is a Modifiable Risk Factor

Unlike age or underlying disease, sedation practices can be changed. The study highlights deep sedation as a modifiable risk factor, offering clinicians a tangible lever to potentially improve long-term outcomes for surgical ICU survivors. Lighter sedation practices, such as those using dexmedetomidine, may reduce mortality and improve quality of life after critical illness.

The Road Ahead: More Research Needed

While this study provides strong evidence of an association between early deep sedation and long-term mortality, it is retrospective and based at a single center. Prospective, multicenter studies are needed to confirm these findings and guide future sedation protocols in critical care.

Key Takeaways

Early deep sedation in surgical ICU patients is linked to higher one-year mortality after hospital discharge.

The risk remains significant even after adjusting for illness severity and comorbidities.

Sedatives like midazolam and propofol carry higher long-term risk than dexmedetomidine.

Lighter sedation may be a safer strategy for critically ill surgical patients.

Sedation depth is a modifiable factor, representing a key target for improving patient outcomes.

Citation:

Wu P-Y, Lee S-Y, Wong L-T, Chao W-C. Early deep sedation was associated with post-hospital one-year mortality in critically ill surgical patients: a propensity-matched retrospective cohort study. BMC Anesthesiology. 2025;25:268. https://doi.org/10.1186/s12871-025-03137-4